L
Luz Fonacier
Researcher at Winthrop-University Hospital
Publications - 89
Citations - 2773
Luz Fonacier is an academic researcher from Winthrop-University Hospital. The author has contributed to research in topics: Atopic dermatitis & Medicine. The author has an hindex of 24, co-authored 72 publications receiving 1708 citations. Previous affiliations of Luz Fonacier include Stony Brook University & New York University.
Papers
More filters
Journal ArticleDOI
Patient burden and quality of life in atopic dermatitis in US adults: A population-based cross-sectional study
Jonathan I. Silverberg,Joel M. Gelfand,David J. Margolis,Mark Boguniewicz,Luz Fonacier,Mitchell H. Grayson,Eric L. Simpson,Peck Y. Ong,Zelma C. Chiesa Fuxench +8 more
TL;DR: These data support the heavy burden that AD places on patients, particularly those with moderate and severe AD.
Journal ArticleDOI
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria.
Torsten Zuberbier,Amir Hamzah Abdul Latiff,Mohamed Abuzakouk,S. Aquilina,Riccardo Asero,Diane Baker,Barbara Ballmer-Weber,Barbara Ballmer-Weber,Christine Bangert,Moshe Ben-Shoshan,Jonathan A. Bernstein,Carsten Bindslev-Jensen,Knut Brockow,Zenon Brzoza,Herberto José Chong Neto,Martin K. Church,Martin K. Church,Paulo Ricardo Criado,I V Danilycheva,Corinna Dressler,Luis Felipe Ensina,Luz Fonacier,Matthew Gaskins,Krisztián Gáspár,Aslı Gelincik,A. Giménez-Arnau,Kiran Godse,Margarida Gonçalo,Clive Grattan,Martine Grosber,Eckard Hamelmann,Jacques Hébert,Michihiro Hide,Allen P. Kaplan,Alexander Kapp,Aharon Kessel,Emek Kocatürk,Kanokvalai Kulthanan,Désirée Larenas-Linnemann,Antti Lauerma,Tabi A. Leslie,Markus Magerl,Markus Magerl,Michael Makris,R. Y. Meshkova,Martin Metz,Martin Metz,Daniel Micallef,Charlotte G. Mortz,Alexander Nast,Hanneke Oude-Elberink,Ruby Pawankar,Paolo D. Pigatto,Hector Ratti Sisa,María Isabel Rojo Gutiérrez,Sarbjit S. Saini,Peter Schmid-Grendelmeier,Bulent Enis Sekerel,Frank Siebenhaar,Frank Siebenhaar,Hanna Siiskonen,Angèle Soria,Petra Staubach-Renz,Luca Stingeni,Gordon Sussman,Andrea Szegedi,Simon Francis Thomsen,Zahava Vadasz,Christian Vestergaard,Bettina Wedi,Zuotao Zhao,Marcus Maurer,Marcus Maurer +72 more
TL;DR: This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS) on 3 December 2020 as mentioned in this paper, with the participation of 64 delegates of 50 national and international societies and from 31 countries.
Journal ArticleDOI
Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population
Zelma C. Chiesa Fuxench,Julie Block,Mark Boguniewicz,John Boyle,Luz Fonacier,Joel M. Gelfand,Mitchell H. Grayson,David J. Margolis,Lynda Mitchell,Jonathan I. Silverberg,Lawrence B. Schwartz,Eric L. Simpson,Peck Y. Ong +12 more
TL;DR: The study confirms the high prevalence and disease burden of atopic dermatitis in the population of the United States, and the distribution of disease severity, and its impact on health-related quality of life.
Journal ArticleDOI
Atopic dermatitis yardstick: Practical recommendations for an evolving therapeutic landscape
Mark Boguniewicz,Luz Fonacier,Emma Guttman-Yassky,Peck Y. Ong,Jonathan I. Silverberg,Judith R Farrar +5 more
TL;DR: The Atopic Dermatitis Yardstick as mentioned in this paper is part of a series developed in response to the need to proactively address the loss of disease control for atopic illnesses at all levels of severity.
Journal ArticleDOI
Expert Perspectives on Management of Moderate-to-Severe Atopic Dermatitis: A Multidisciplinary Consensus Addressing Current and Emerging Therapies
Mark Boguniewicz,Andrew F Alexis,Lisa A. Beck,Julie Block,Lawrence F. Eichenfield,Lawrence F. Eichenfield,Luz Fonacier,Emma Guttman-Yassky,Amy S. Paller,David M. Pariser,Jonathan I. Silverberg,Mark Lebwohl +11 more
TL;DR: A steering committee of AD experts, including dermatologists, allergists, and a patient advocacy group representative, developed recommendations on the basis of a literature review and expert opinion to help clinicians understand how new therapies fit into the current treatment paradigm and to provide practical recommendations for assessing AD severity, treatment response, and treatment failure.